Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Escherichia coli | 7 | 2024 | 700 | 2.430 |
Why?
|
| Microbiota | 3 | 2024 | 128 | 1.530 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 784 | 1.010 |
Why?
|
| Polyketides | 1 | 2024 | 1 | 0.910 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2021 | 51 | 0.860 |
Why?
|
| Biological Evolution | 3 | 2016 | 122 | 0.790 |
Why?
|
| DNA Damage | 1 | 2024 | 280 | 0.780 |
Why?
|
| Adaptation, Physiological | 2 | 2016 | 129 | 0.760 |
Why?
|
| Floxuridine | 1 | 2020 | 5 | 0.700 |
Why?
|
| Peptides | 1 | 2024 | 574 | 0.690 |
Why?
|
| Fluorouracil | 1 | 2020 | 65 | 0.690 |
Why?
|
| Pyrimidines | 1 | 2020 | 137 | 0.650 |
Why?
|
| Mutation | 3 | 2024 | 2607 | 0.650 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 341 | 0.640 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2015 | 559 | 0.630 |
Why?
|
| Education | 1 | 2019 | 68 | 0.610 |
Why?
|
| Robotics | 1 | 2019 | 87 | 0.570 |
Why?
|
| Information Dissemination | 1 | 2019 | 116 | 0.570 |
Why?
|
| Osmotic Pressure | 2 | 2015 | 16 | 0.570 |
Why?
|
| Melanoma | 1 | 2021 | 331 | 0.560 |
Why?
|
| Signal Transduction | 4 | 2021 | 3033 | 0.550 |
Why?
|
| Cell Physiological Phenomena | 1 | 2016 | 12 | 0.520 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 412 | 0.510 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 217 | 0.450 |
Why?
|
| Caenorhabditis elegans | 1 | 2020 | 677 | 0.420 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2023 | 41 | 0.370 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2015 | 441 | 0.360 |
Why?
|
| Adaptation, Biological | 1 | 2011 | 18 | 0.360 |
Why?
|
| Vibrio cholerae | 1 | 2011 | 18 | 0.350 |
Why?
|
| Yeasts | 1 | 2011 | 49 | 0.350 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2023 | 197 | 0.350 |
Why?
|
| Ecosystem | 1 | 2011 | 53 | 0.340 |
Why?
|
| Environment | 2 | 2012 | 122 | 0.320 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 1465 | 0.310 |
Why?
|
| Evolution, Molecular | 3 | 2012 | 322 | 0.270 |
Why?
|
| Phylogeny | 2 | 2005 | 376 | 0.270 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 187 | 0.270 |
Why?
|
| Pseudogenes | 1 | 2005 | 12 | 0.250 |
Why?
|
| Mycobacterium leprae | 1 | 2005 | 6 | 0.250 |
Why?
|
| Models, Biological | 1 | 2011 | 1177 | 0.240 |
Why?
|
| Symbiosis | 2 | 2021 | 32 | 0.220 |
Why?
|
| Genome, Bacterial | 1 | 2024 | 67 | 0.220 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2024 | 93 | 0.220 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 203 | 0.200 |
Why?
|
| Deoxycytidine | 1 | 2023 | 42 | 0.200 |
Why?
|
| Escherichia coli Proteins | 1 | 2024 | 269 | 0.190 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 158 | 0.190 |
Why?
|
| Microbial Consortia | 1 | 2021 | 10 | 0.180 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 83 | 0.180 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2020 | 9 | 0.180 |
Why?
|
| Humans | 9 | 2024 | 63292 | 0.180 |
Why?
|
| Antimetabolites | 1 | 2020 | 18 | 0.180 |
Why?
|
| Vitamins | 1 | 2021 | 80 | 0.170 |
Why?
|
| Directed Molecular Evolution | 1 | 2020 | 10 | 0.170 |
Why?
|
| Whole Genome Sequencing | 1 | 2020 | 81 | 0.170 |
Why?
|
| Cell Lineage | 1 | 2021 | 268 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 89 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 1 | 2021 | 400 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 226 | 0.160 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 174 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2020 | 308 | 0.160 |
Why?
|
| Automation | 1 | 2019 | 54 | 0.160 |
Why?
|
| Community-Institutional Relations | 1 | 2019 | 38 | 0.160 |
Why?
|
| Technology | 1 | 2019 | 52 | 0.150 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2018 | 14 | 0.150 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 56 | 0.150 |
Why?
|
| Molecular Docking Simulation | 1 | 2018 | 79 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 71 | 0.140 |
Why?
|
| Teaching | 1 | 2019 | 159 | 0.140 |
Why?
|
| Schools | 1 | 2019 | 166 | 0.140 |
Why?
|
| Bacteria | 2 | 2020 | 304 | 0.140 |
Why?
|
| Cell Proliferation | 1 | 2021 | 985 | 0.130 |
Why?
|
| Students | 1 | 2019 | 217 | 0.130 |
Why?
|
| Eukaryota | 1 | 2016 | 29 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 1617 | 0.130 |
Why?
|
| Neoplasms | 2 | 2020 | 1359 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 663 | 0.120 |
Why?
|
| Osmolar Concentration | 1 | 2015 | 89 | 0.120 |
Why?
|
| Internet | 1 | 2019 | 469 | 0.120 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 195 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2015 | 268 | 0.110 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 3 | 0.100 |
Why?
|
| Aneuploidy | 1 | 2012 | 42 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 670 | 0.090 |
Why?
|
| Chromosomes | 1 | 2012 | 135 | 0.090 |
Why?
|
| Animals | 4 | 2020 | 20631 | 0.090 |
Why?
|
| Lactose | 1 | 2009 | 10 | 0.080 |
Why?
|
| Maltose | 1 | 2009 | 12 | 0.080 |
Why?
|
| Cell Respiration | 1 | 2009 | 21 | 0.080 |
Why?
|
| Heat-Shock Response | 1 | 2009 | 34 | 0.080 |
Why?
|
| Carbohydrate Metabolism | 1 | 2009 | 49 | 0.080 |
Why?
|
| Carbon | 1 | 2009 | 51 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2012 | 260 | 0.080 |
Why?
|
| Fermentation | 1 | 2009 | 48 | 0.080 |
Why?
|
| Adolescent | 1 | 2019 | 6238 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2009 | 297 | 0.070 |
Why?
|
| Genomics | 1 | 2009 | 370 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 87 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 240 | 0.050 |
Why?
|
| Time Factors | 1 | 2009 | 3759 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2005 | 1148 | 0.040 |
Why?
|
| Oncogenic Viruses | 1 | 2020 | 2 | 0.040 |
Why?
|
| Gastritis | 1 | 2020 | 18 | 0.040 |
Why?
|
| Environmental Microbiology | 1 | 2020 | 14 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 2020 | 36 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 142 | 0.040 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 55 | 0.040 |
Why?
|
| Algorithms | 1 | 2005 | 1001 | 0.040 |
Why?
|
| Probiotics | 1 | 2020 | 46 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 78 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 110 | 0.040 |
Why?
|
| Optogenetics | 1 | 2018 | 32 | 0.040 |
Why?
|
| Male | 1 | 2019 | 29814 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 130 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 197 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2018 | 174 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2020 | 255 | 0.030 |
Why?
|
| Female | 1 | 2019 | 32787 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 262 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 569 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 620 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 236 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 778 | 0.030 |
Why?
|
| Mice | 2 | 2020 | 10827 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 771 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 536 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2018 | 2107 | 0.030 |
Why?
|
| Haploidy | 1 | 2012 | 11 | 0.030 |
Why?
|
| Genes, Fungal | 1 | 2012 | 55 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 64 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2012 | 130 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 147 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2012 | 289 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.020 |
Why?
|
| Temperature | 1 | 2012 | 307 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 3391 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 457 | 0.020 |
Why?
|
| Phenotype | 1 | 2012 | 1200 | 0.020 |
Why?
|
| Markov Chains | 1 | 2005 | 37 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2005 | 87 | 0.010 |
Why?
|
| Potassium Channels | 1 | 2005 | 58 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2005 | 122 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 174 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2005 | 477 | 0.010 |
Why?
|